Evidence-based equipoise and research responsiveness

American Journal of Bioethics

Volumn 6, Issue 4, 2006, Pages 1-4

  Halpern, Scott ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BCG VACCINE; ZIDOVUDINE;

ATTITUDE TO HEALTH; CLINICAL TRIAL; EDITORIAL; ETHICS; EVIDENCE BASED MEDICINE; HUMAN; HUMAN EXPERIMENT; METHODOLOGY; STANDARD;

AMLODIPINE; ANTI-HIV AGENTS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BCG VACCINE; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMAN EXPERIMENTATION; HUMANS; RESEARCH DESIGN; ZIDOVUDINE;

EID: 33746822624     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160600843528     Document Type: Editorial

References (33)

1. Angell, M. 1997. The ethics of clinical research in the third world. New England Journal of Medicine 337: 847-849.
2. Annas, G. J, and M. A. Grodin. 1998. Human rights and maternal-fetal HIV transmission prevention trials in Africa. American Journal of Public Health 88: 560-563.
3. Ashscroft, R. 1999. Equipoise, knowledge and ethics in clinical research and practice. Bioethics 13: 314-326.
4. Bloom, B. R. 1998. The highest attainable standard: Ethical issues in AIDS vaccines. Science 279: 186-188.
5. Cardiac Arrhythmia Suppression Trial (CAST) I. 1989. Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 321: 406-412.
6. Chiong, W. 2006. The real problem with equipoise. American Journal of Bioethics 6(4): 37-47.
7. Cobb, L. A., G. I. Thomas, D. H. Dillard, K. A. Merendino, and R. A. Bruce. 1959. An evaluation of internal-mammary-artery ligation by double-blind technic. New England Journal of Medicine 260: 1115-1118.
8. Connors , A. F. Jr., T. Speroff, N. V. Dawson, C. Thomas, F. E. Harrell Jr., D. Wagner, N. Desbiens, L. Goldman, A. W. Wu, R. M. Califf, W. J. Fulkerson Jr., H. Vidaillet, S. Broste, P. Bellamy, J. Lynn, and W. A. Knaus. 1996. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. Journal of the American Medical Association 276: 889-897.
9. Dahlof, B., P. S. Sever, N. R. Poulter, H. Wedel, D. G. Beevers, M. Caulfield, R. Collins, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, and J. Ostergren for the ASCOT Investigators. 2005. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet 366: 895-906.
10. Fried, C. 1974. Medical experimentation: Personal integrity and social policy. Amsterdam: North-Holland Publishing.
11. Freedman, B. 1987. Equipoise and the ethics of clinical research. New England Journal of Medicine 317: 141-145.
12. Freeman, T. B., D. E. Vawter, P. E. Leaverton, J. H. Godbol, R. A. Hauser, C. G. Goetz, and C. W. Olanow. 1999. Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's Disease. New England Journal of Medicine 341: 988-992.
13. Gifford, F. 2000. Freedman's 'clinical equipoise' and 'slidingscale all-dimensions-considered equipoise'. Journal of Medicine and Philosophy 25: 399-426.
14. Halpern, S. D. 2005. Towards evidence based bioethics. British Medical Journal 331: 901-903.
15. Halpern, S. D., J. H. Karlawish, and C. Weijer. 2001. Informing patients of uncertainty in clinical trials. Journal of the American Medical Association 285: 2713-2714.
16. Halpern, S. D., J. H. T. Karlawish, and J. A. Berlin. 2002. The continuing unethical conduct of underpowered clinical trials. Journal of the American Medical Association 288: 358-362.
17. Karlawish, J. H. T., and J. Lantos. 1997. Community equipoise and the architecture of clinical research. Cambridge Quarterly of Healthcare Ethics 6: 385-396.
18. Kerin, J. 1998. Double standards: Principled or arbitrary? Bioethics 12: iii-vii.
19. Macklin, R. 2001. After Helsinki: Unresolved issues in international research. Kennedy Institute Ethics Journal 11: 17-36.
20. Mbiddle, E. 1998. Bioethics and local circumstances. Science 279: 155.
21. Meier, D. E. 2004. Variability in end of life care. British Medical Journal 328: 15.
22. The National Heart Lung and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. 2006. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. New England Journal of Medicine 354: 2213-2224.
23. Psaty, B. M., N. S. Weiss, and C. D. Funrberg. 2006. Recent trials in hypertension: Compelling science or commercial speech? Journal of the American Medical Association 295: 1704-1706.
24. Robin, E. D. 1985. The cult of the Swan-Ganz catheter: Overuse and abuse of pulmonary flow catheters. Annals of Internal Medicine 103: 445-449.
25. Sackett, D. L. 2002. Clinical epidemiology: What, who, and whither. Journal of Clinical Epidemiology 55: 1161-1166.
26. Schuklenk, U. 2000. Protecting the vulnerable: Testing times for clinical research ethics. Social Science and Medicine 51: 969-977.
27. Shah, M. R., V. Hasselblad, L. W. Stevenson, C. Binanay, C. M. O'Connor, G. Sopko, and R. M. Califf. 2005. Impact of the pulmonary artery catheter in critically ill patients: Meta-analysis of randomized clinical trials. Journal of the American Medical Association 294: 1664-1670.
28. Smith, G. C. S., and J. P. Pell. 2003. Parachute use to prevent death and major trauma related to gravitational challenge: Systematic review of randomised controlled trials. British Medical Journal 327: 1459-1461.
29. Snider, Jr., D. 2000. Ethical issues in tuberculosis vaccine trials. Clinical Infectious Disease 30(Suppl 3): S271-S275.
30. Temple, R., and S. S. Ellenberg. 2000. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: Ethical and scientific issues. Annals of Internal Medicine 133: 455-463.
31. Tollman, S. M. 2001. What are the effects of the fifth revision of the Declaration of Helsinki? Fair partnerships support ethical research. British Medical Journal 323: 1417-1419.
32. Varmus, H., and D. Satcher. 1997. Ethical complexities of conducting research in developing countries. New England Journal of Medicine 337: 1003-1005.
33. Wennberg, J. E., E. S. Fisher, T. A. Stukel, J. S. Skinner, S. M. Sharp, and K. K. Bronner. 2004. Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States. British Medical Journal 328: 13.